Elizabeth Murphy Lilly - Dec 29, 2023 Form 4 Insider Report for APOGEE ENTERPRISES, INC. (APOG)

Role
Director
Signature
/s/ Meghan M. Elliott, Attorney-in-Fact for Elizabeth Murphy Lilly
Stock symbol
APOG
Transactions as of
Dec 29, 2023
Transactions value $
$427
Form type
4
Date filed
1/3/2024, 02:45 PM
Previous filing
Oct 3, 2023
Next filing
Apr 1, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APOG Deferred Restricted Stock Units Award $427 +8 +0.44% $53.41 1.82K Dec 29, 2023 Common Stock 8 $0.00 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The deferred restricted stock units were allocated under the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person or following the occurrence of other events specified in the Plan.
F2 Settled 1-for-1.
F3 Additional deferred restricted stock units were allocated pursuant to a dividend equivalent reinvestment feature of the 2019 Non-Employee Director Stock Plan.